10-Q//Quarterly update
Aspreva Pharmaceuticals CORP 10-Q
Accession 0000945234-07-000653
CIK 0001314026operating
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 5, 5:47 PM ET
Size
651.3 KB
Accession
0000945234-07-000653
Documents
- 10-Qo38269e10vq.htmPrimary
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2007
- EX-10.39o38269exv10w39.htm
FOURTH AMENDMENT TO CELLCEPT COLLABORATION
- EX-10.40o38269exv10w40.htm
SUPPORT AGREEMENT DATED AUGUST 28, 2007
- EX-31.1o38269exv31w1.htm
SECTION 302 C.E.O. CERTIFICATION
- EX-31.2o38269exv31w2.htm
SECTION 302 C.F.O. CERTIFICATION
- EX-32.1o38269exv32w1.htm
SECTION 906 C.E.O. CERTIFICATION
- EX-32.2o38269exv32w2.htm
SECTION 906 C.F.O. CERTIFICATION
- GRAPHICo38269o3826900.gif
GRAPHIC
Issuer
Aspreva Pharmaceuticals CORP
CIK 0001314026
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001314026
Filing Metadata
- Form type
- 10-Q
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 5, 5:47 PM ET
- Size
- 651.3 KB